| Clinical pharmacokinetics and pharmacodynamics of telavancin compared with the other glycopeptides V Al Jalali, M Zeitlinger Clinical Pharmacokinetics 57, 797-816, 2018 | 29 | 2018 |
| Clinical pharmacokinetics of fosfomycin after continuous infusion compared with intermittent infusion: a randomized crossover study in healthy volunteers V Al Jalali, P Matzneller, B Wulkersdorfer, S Chou, S Bahmany, BCP Koch, ... Antimicrobial Agents and Chemotherapy 65 (1), 10.1128/aac. 01375-20, 2020 | 16 | 2020 |
| Systemic and target-site pharmacokinetics of antiparasitic agents V Al Jalali, M Zeitlinger Clinical Pharmacokinetics 59 (7), 827-847, 2020 | 13 | 2020 |
| In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid V Al Jalali, R Sauermann, S Eberl, M Zeitlinger Infection 47, 565-570, 2019 | 11 | 2019 |
| Meropenem concentrations in brain tissue of neurointensive care patients exceed CSF levels A Hosmann, L Ritscher, H Burgmann, V Al Jalali, B Wulkersdorfer, ... Journal of Antimicrobial Chemotherapy 76 (11), 2914-2922, 2021 | 10 | 2021 |
| Phase I study to assess safety of laser-assisted topical administration of an anti-TNF biologic in patients with chronic plaque-type psoriasis M Bauer, E Lackner, P Matzneller, V Al Jalali, S Pajenda, V Ling, C Böhler, ... Frontiers in Medicine 8, 712511, 2021 | 10 | 2021 |
| Protein binding of clindamycin in vivo by means of intravascular microdialysis in healthy volunteers B Wulkersdorfer, SG Wicha, E Kurdina, SF Carrion Carrera, P Matzneller, ... Journal of Antimicrobial Chemotherapy 76 (8), 2106-2113, 2021 | 9 | 2021 |
| Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers AE Edwina, BCP Koch, AE Muller, V Al Jalali, P Matzneller, M Zeitlinger, ... European Journal of Clinical Pharmacology 79 (6), 775-787, 2023 | 6 | 2023 |
| Comparison of ultrafiltration and microdialysis for ceftriaxone protein-binding determination M Sanz-Codina, SG Wicha, B Wulkersdorfer, V Al Jalali, W Van Os, ... Journal of Antimicrobial Chemotherapy 78 (2), 380-388, 2023 | 6 | 2023 |
| Hemodynamic and rhythmologic effects of push-dose landiolol in critical care—a retrospective cross-sectional study S Schnaubelt, F Eibensteiner, J Oppenauer, D Tihanyi, M Neymayer, ... Pharmaceuticals 16 (2), 134, 2023 | 6 | 2023 |
| Consecutive prostate-specific membrane antigen (PSMA) and antigen receptor (AR) PET imaging shows positive correlation with AR and PSMA protein expression in primary hormone … V Al Jalali, G Wasinger, S Rasul, B Grubmüller, B Wulkersdorfer, T Balber, ... Journal of Nuclear Medicine 64 (6), 863-868, 2023 | 5 | 2023 |
| Plasma and Lung Tissue Pharmacokinetics of Ceftaroline Fosamil in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass: an In Vivo Microdialysis … M Edlinger-Stanger, V Al Jalali, M Andreas, W Jäger, M Böhmdorfer, ... Antimicrobial Agents and Chemotherapy 65 (10), 10.1128/aac. 00679-21, 2021 | 5 | 2021 |
| Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions F Bergmann, M Wölfl-Duchek, A Jorda, V Al Jalali, A Leutzendorff, ... Journal of Antimicrobial Chemotherapy 79 (5), 1169-1175, 2024 | 4 | 2024 |
| Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors S Büsker, W Jäger, S Poschner, L Mayr, V Al Jalali, J Gojo, AA Azizi, ... Cancer Chemotherapy and Pharmacology 89 (5), 617-627, 2022 | 3 | 2022 |
| Influence of tedizolid on the cytokine response to the endotoxin challenge in healthy volunteers: a cross-over trial A Jorda, B Wulkersdorfer, C Schörgenhofer, P Matzneller, V Al Jalali, ... Journal of Antimicrobial Chemotherapy 77 (5), 1424-1431, 2022 | 3 | 2022 |
| Plasma and soft tissue pharmacokinetics of ceftolozane/tazobactam in healthy volunteers after single and multiple intravenous infusion: a microdialysis study V Al Jalali, M Wölfl-Duchek, M Taubert, P Matzneller, E Lackner, C Dorn, ... Journal of Antimicrobial Chemotherapy 76 (9), 2342-2351, 2021 | 3 | 2021 |
| Linezolid brain penetration in neurointensive care patients A Hosmann, MM Moser, W van Os, L Gramms, V Al Jalali, M Sanz Codina, ... Journal of Antimicrobial Chemotherapy 79 (3), 669-677, 2024 | 2 | 2024 |
| Effect of albumin substitution on pharmacokinetics of piperacillin/tazobactam in patients with severe burn injury admitted to the ICU B Wulkersdorfer, F Bergmann, L Amann, A Fochtmann-Frana, V Al Jalali, ... Journal of Antimicrobial Chemotherapy 79 (2), 262-270, 2024 | 2 | 2024 |
| Plasma and intraperitoneal pharmacokinetics of ceftazidime/avibactam in peritoneal dialysis patients V Al Jalali, P Matzneller, AD Pham, W van Os, M Wölfl-Duchek, ... Clinical Microbiology and Infection 29 (9), 1196. e1-1196. e7, 2023 | 2 | 2023 |
| Pilot pharmacokinetic study in healthy adults using intravascular microdialysis catheters modified for use in paediatric patients to assess vancomycin blood levels V Al Jalali, M Bauer, M Wölfl-Duchek, M Sarhan, SG Wicha, S Poschner, ... Clinical Pharmacokinetics 62 (1), 77-87, 2023 | 2 | 2023 |
